Qualcomm Life extends telehealth ecosystem through project in France and UK
March 3, 2015
Qualcomm Life has grown its member ecosystem through collaborations with the CHU of Limoges in France and TBS in the UK, the California-based company announced this week at Mobile World Congress in Barcelona.
The CHU of Limoges (Centre Hospitalier Universitaire de Limoges) is using Qualcomm Life’s CE-listed and Continua-certified 2net platform and hub to serve as the biometric data connectivity infrastructure for its ICare chronic care management programme in France. TBS, a health care technology management service provider, is also using the 2net platform in telehealth programmes and has already seen compelling results with improved health outcomes and patient satisfaction.
ICare is a large-scale pilot project that aims to evaluate the medico-social, economic and organisational impacts of home health technology for at-risk patients living in rural areas, focused specifically on avoiding and reducing hospital re-admissions. The CHU of Limoges deployed its connected health services in 550 homes in rural regions including Corrèze, Creuse, Haute-Vienne and Loir-et-Cher, where 45% of the patients are aged 65 or older to measure the benefits of connected health when there is lower access to traditional care services.
ICare leverages the 2net platform and hub to enable seamless remote monitoring capabilities, allowing general practitioners and nurses to stratify patients, coordinate care and keep patients living at home longer.
“We recognise Qualcomm Life as a true leader in the connected health space, and have selected its 2net technology because it offers unprecedented interoperability and is device agnostic,” said Thierry Dantoine, head of the geriatric unit at the Limoges Centre Hospitalier Universitaire (University Hospital) (CHU). “Qualcomm Life offers a flexible, secure enterprise grade solution that will enable us to scale our offering, ultimately helping more patients better manage their long-term conditions.”
TBS specialises in the management of health care technology, provides telehealth technology and logistics support to Orla Healthcare, a private provider of home health services, in integrated care pilots in the UK. Focused on streamlining transitions of care, its first pilot with 400 patients saved 2000 hospital bed-stays, had zero unavoidable re-admissions and saw a 99% patient satisfaction rating.
Patients in the pilot were admitted to, Princess Alexandra Hospital, an NHS hospital in Harlow, UK, but treatment was provided at home with a telemedicine kit comprised of a blood pressure monitor, a pulse oximeter, a telecare device (GPS location system and alarm button) and a 2net hub to capture and transmit biometric data from the patient’s home to the round-the-clock clinical support team. The patient data were visualised using Medixine Clinic,cloud-based software that enables biometric data visualisation, triage management and at-risk patient population management.
“For years mobile health has remained a nascent category with small-scale deployments and little evidence capture,” said Laurent Vandebrouck, senior director of Qualcomm Life in Europe. “The strong outcomes data we are seeing from our collaboration with TBS and Medixine is one of many examples where a clear RoI is demonstrated by using connected health technologies.”
TBS and Orla Healthcare have now extended the pilot to include early discharge of ward patients, transitioning in-patients from hospital wards and treating them at home. This service is unique within the NHS and is made possible by Orla’s consultant led team and TBS’s technology enabled by 2net.
Qualcomm Life has grown its ecosystem to nearly 500 member companies in the USA and Europe, comprised of leading pharmaceuticals, telehealth service providers, medical device manufacturers and more.